Fabtech Technologies Limited (FABTECH) fundamentals
Fabtech Technologies Limited is a listed company in Healthcare Equipment & Supplies, part of the Healthcare sector, listed on the NSE as FABTECH (ISIN INE0HF201011). This page carries its reported financials, balance sheet, cash flow, shareholding pattern and valuation ratios.
What Fabtech Technologies Limited does
Fabtech Technologies Ltd. is an India-based transnational pharmaceutical engineering company. It offers end-to-end solutions across the pharmaceutical, biotechnology, and healthcare sectors. The Company focuses on bio clean air, clean water, and process requirements, delivering solutions that span the entire project lifecycle for its customers. It covers various dosage forms, including liquids, solids, and semisolids, across the pharmaceutical value chain. Its turnkey engineering services encompass market analysis, disease profiling, custom equipment design, and the application of advanced technologies to project execution. Its expertise spans across executing a diverse array of projects and solutions, including granulation solutions, isolator containment systems, injectable projects, encapsulation solutions, cleanroom infrastructure, cleanroom systems, cleanroom equipment, heating, ventilation, and air conditioning systems, mechanical, electrical and plumbing and packaging lines.
Valuation and market data
| Last close | ₹146.20 |
|---|---|
| Market capitalisation | ₹474 crore |
| Enterprise value | ₹492 crore |
| P/E (TTM) | 0.00 |
| Price to book | 2.74 |
| Price to sales (TTM) | 1.07 |
| Book value per share | ₹53.44 |
| Dividend yield | 41.04% |
| Sector | Healthcare |
| Industry | Healthcare Equipment & Supplies |
| Listed since | Tue Oct 07 |
Annual results
| Period | Revenue | Profit before tax | Net profit | EPS |
|---|---|---|---|---|
| Mar 2026 | ₹431 crore | ₹48 crore | ₹38 crore | 0.00 |
| Mar 2025 | ₹336 crore | ₹60 crore | ₹46 crore | 14.34 |
| Mar 2024 | ₹231 crore | ₹36 crore | ₹27 crore | 8.43 |
| Mar 2023 | ₹200 crore | ₹28 crore | ₹22 crore | 6.74 |
| Mar 2022 | ₹260 crore | ₹31 crore | ₹23 crore | 7.28 |
Figures are as reported (consolidated), in ₹ crore.
Shareholding pattern
As of Jun 2026:
| Promoters | 68.9% |
|---|---|
| Foreign institutions (FII) | 0.0% |
| Mutual funds | 0.0% |
| Other domestic institutions | 2.5% |
| Retail and others | 28.6% |
More on BreakPoint
FundaX company research covers every listed company with reported financials. BreakPoint Pro adds the BreakPoint iQ score, the screener and the multibagger board.
Data is sourced from exchange filings and vendor feeds and is for research, not investment advice. Figures can be restated by the company after publication.